Tag: Thyroid cancer
-
Understanding the Global Rise in Thyroid Cancer: Causes, Trends, and Outlook
Why Thyroid Cancer Rates Are Rising Globally Thyroid cancer has shown a noticeable uptick in many parts of the world, with some regions reporting faster growth in incidence than other cancers. While this trend has sparked concern, experts say multiple factors—not a single culprit—are shaping the numbers. Understanding these drivers helps clarify whether the rise…
-
Why Thyroid Cancer Rates Are Rising Worldwide: Real Increases or Overdiagnosis?
Understanding the Global Rise in Thyroid Cancer Across many countries, thyroid cancer rates have climbed faster than those of other cancers. In places like the United States, the increase has been notable, prompting questions about whether more cancers are truly occurring or simply detected sooner. To understand this trend, it helps to separate real changes…
-
Why Thyroid Cancer Rates Are Rising Worldwide: Causes and Trends
Overview: A Global Rise in Thyroid Cancer Thyroid cancer incidence has been increasing in many parts of the world, and in some places the rise appears faster than for other cancers. While heightened awareness and better detection play a major role, researchers are digging deeper to understand additional contributing factors. This article examines what’s behind…
-
Sobrinho Simões: Most Cancers Could Be Controllable in 20–30 Years
Vision for a Future Where Cancer is Controllable Manuel Sobrinho Simões, a renowned pathologist and founder of IPATIMUP in Porto, has long been a beacon for cancer research in Portugal. At 78, he remains deeply engaged with science, training new generations, and translating research into public health impact. He predicts a hopeful future: within 20…
-
Sobrinho Simões: Cancer Control, Thyroid Awareness, and Portugal’s Scientific Path
Portugal’s Medical Trailblazer on the Horizon of Cancer Control Manuel Sobrinho Simões, a physician-scientist celebrated for his long-standing leadership in cancer research, looks to a future where cancers are managed more as chronic conditions than as existential threats. In an interview with Campeão das Províncias, he blends reflections on the past with bold predictions: within…
-
Thyroid Cancer Insight: 95% Control in 20–30 Years, Says MSS
A lifetime of leadership in cancer research Manuel Sobrinho Simões, a towering figure in European pathology and the founder of IPATIMUP (Institute of Molecular Pathology and Immunology of the University of Porto), has long shaped Portugal’s course in cancer research. Recognized in 2015 by The Pathologist as the world’s most influential pathologist, his work sits…